1. Market Research
  2. > Retail
  3. > In-Store Retail Market Trends
Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product ; Application ; Distribution Channel, and Geography

Patient Controlled Injectors Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product ; Application ; Distribution Channel, and Geography

  • November 2020
  • 175 pages
  • ID: 6010085
  • Format: PDF
  • The Insight Partners
Up to $1700 off Until Apr 20th 2021

Summary

Table of Contents

Search Inside

The patient controlled injectors market was valued at US$ 2,969.47 million in 2019 and is projected to reach US$ 7,505.70 million by 2027; it is expected to grow at a CAGR of 12.4% during 2020–2027. The growth of the patient controlled injectors market is mainly attributed to the factors such as increasing prevalence of chronic diseases and rising patient compliance. However, lack of adoption in emerging countries is likely to restraint the growth of the market during the forecast years.

Patient-controlled injectors are expected to rise concurrently in the market owing to greater ease, safety, and comfort of the administration of injections, which is likely to gain significant popularity among patients. Additionally, the controlled release of the patient-controlled injectors helps the patient administer the drug by themselves and decide their dosage rate.

Besides, the patient-controlled injectors can be administered at home settings, and thus, there is an increase in demand for patient-controlled injectors.Patient-controlled injectors present a strong solution for higher dosing volumes in non-clinical settings.

Large volume of patient-controlled injectors are used for subcutaneous drug delivery at home care setting.Variants like these patient controlled self-administration devices are especially designed to administer highly viscous medications in large volumes.

As per the WHO, ~2 million healthcare workers experience percutaneous exposure to infectious diseases each year. It further reveals that 37.6% of Hepatitis B and 4.4% of HIV/AIDS infections in healthcare workers are due to needle stick injuries worldwide. Many manufacturers are now focusing on developing patient-controlled injectors to meet the unmet needs, which, in turn, is stimulating the growth of the market. The easy administration of these drugs plays a crucial role in improving the compliance to drug therapies among patients, which drives patient outcomes. Considering these factors, the preference for controlled injectors, such as self-dose and Tremfya, is increasing among patients and healthcare providers. Besides, this self-injector is considered safe and efficacious among patients. For instance, according to a clinical trial report of July 2019, Guselkumab administered using the one-press patient controlled injector was very efficacious and well-tolerated in moderate-to-severe psoriasis patients. The researchers concluded that one-press controlled injector was highly acceptable over conventional drug delivery. Thus, unlike other drug delivery routes, this innovative route of administration does not require rigorous sterile methods for administering drugs into the body. Therefore, increasing preference for patient-controlled injectors among patients and health care providers, due to growing awareness regarding its benefits, is driving the market growth.

The demand for patient controlled injectors increased during the pandemic.Factors such as increased patient population, shortage of healthcare resources, and ease of increased the adoption of injectors had positive impact on the market by certain extent.

However, implementation of physical distancing policies and total shut down of businesses in order to prevent the viral infection disrupted the supply chain operations, which caused a negative impact on the market growth.

Based on product, the patient controlled injectors market is segmented into electronic wearable injector, mechanical wearable injector, and infusion pumps. In 2019, the electronic wearable segment held the largest share of the market, whereas, the mechanical wearable injector segment is projected to register the highest CAGR in the market during the forecast period.

Based on application, the patient controlled injectors market is segmented into cancer treatment, auto-immune treatment, blood disorders treatment, and others. The cancer treatment segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.

Based on distribution channel, the patient controlled injectors market is segmented into hospital pharmacies, retail pharmacies, and mail order pharmacies. The hospital pharmacies segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.

The World Health Organization (WHO), Food and Drug Administration (FDA), NHS (National Health Service), and Centers for Disease Control and Prevention are among the major primary and secondary sources referred for preparing this report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

$4500

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Medical Loupes Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type ; Lens Type ; Application ; Distribution Channel, and Geography

  • $ 4550
  • February 2021
  • 171 pages

The global medical loupes market is expected to reach US$ 658.49 million by 2027 from US$ 393.64 million in 2019. The market is estimated to grow at a CAGR of 6.8% from 2020 to 2027. Increasing product ...

  • World
  • APAC
  • In-Store Retail
  • Application
  • Industry analysis
  • Oral Surgeries
  • Health Expenditure

Hearing Aids Markets in China $ 4000 February 2021


ref:plp2020

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on